| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.6M | +41.5% |
| Cost of Revenue | $25.3M | +46.8% |
| Gross Profit | $2.2M | +0.0% |
| R&D Expense | $16.1M | +14.4% |
| SG&A Expense | $64.6M | -21.9% |
| Operating Income | -$116.9M | -23.7% |
| Income Tax | $0 | — |
| Net Income | -$124.0M | -11.7% |
| EPS (Basic) | -$15.61 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.3M | -24.4% |
| Accounts Receivable | $3.1M | +14.4% |
| Inventory | $4.2M | +17.1% |
| Current Assets | $27.0M | -20.9% |
| Total Assets | $381.8M | +37.0% |
| Current Liabilities | $31.9M | +37.3% |
| Long-term Debt | $278.0M | +132.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.2M | +32.1% |
| Capital Expenditures | $162.3M | +189.7% |
| Investing Cash Flow | -$162.3M | +5.9% |
| Financing Cash Flow | $187.4M | +29.2% |
| Free Cash Flow | -$195.4M | -86.4% |
| -1129.1% |
| EPS (Diluted) | -$15.61 | -1129.1% |
| Total Liabilities |
| $366.5M |
| +132.8% |
| Stockholders' Equity | $15.3M | -87.4% |